Goals of care addressing disparities and variation for alzheimer's disease nursing home care at end of life

Active Grant Awarded Last action

Award ID
R01AG091541
Recipient
Awarding agency
Obligated
$1,628,644

Award facts

Assistance listing
93.866 Aging Research
Completion date 24% complete
Place of performance
Chapel Hill, NC 27514, USA

Award details come from USAspending.gov.

Description

Abstract
Alzheimer's disease and related dementias (ADRD) disproportionately impact black americans. Most people with ADRD and their family decision-makers prioritize comfort, yet burdensome interventions and lack of shared decision-making about goals of care are common in NHS with a high proportion of black residents. Evidence supports systematic communication interventions to address practice variation in shared decisionmaking about treatment, with resulting difference in quality of care and outcomes. An experienced team of investigators proposes GOC advance (goals of care- addressing variation for alzheimer's disease nursing home care at end of life), a clinical trial conducted in NHS with a high proportion of black american residents. The over-arching premise is that GOC advance will improve communication and treatment decisions in latestage ADRD. Research design uses the RE-aim framework to assess implementation and impact, in partnership with community advisors to optimize implementation. The specific aims are: aim 1. To conduct a real-world efficacy cluster RCT (NIA stage III) comparing 3-month communication outcomes among ADRD decision-makers in NHS randomized to the GOC advance intervention VS usual care. NHS with > 35% black residents will be randomized to intervention VS. Usual care (16 NHS, N=8 NHS/arm). Participants will be family decision-makers and NH residents with late-stage ADRD (N=300, 150 dyads/arm, >35% black american). Communication outcomes ascertained in decision-maker interviews at 3 months are: quality of communication (PRIMARY), perceived goal concordance with NH clinicians (SECONDARY), and feeling heard and understood (SECONDARY). Aim 2. To compare 6-month care management outcomes (SECONDARY) between residents in NHS randomized to the GOC advance intervention VS usual care. Outcomes ascertained in decision-maker interviews are: % of decision-makers reporting new decisions for limitations on resuscitation, tube feeding, hospitalization, % with decisions to initiate comfort care or hospice, and number of hospital transfers per persondays. Aim 3. To evaluate the implementation of the GOC advance intervention. Guided by RE-aim (reach, effectiveness, adoption, implementation and maintenance), implementation will be evaluated for black and white dyads using: 1. Quantitative measures (e.g., % decision-makers who viewed the video) and 2. Qualitative data obtained from semi-structured interviews with NH staff (N=16) and family decision-makers (total, N=32; black, N=16; white, N=16) about their experience with the intervention.

Transactions

Action Obligated Date
Amendment $785,240
Original award $843,404

Subawards

Subrecipient Amount Awarded
The University Of Central Florida Board Of Trustees The University of Florida investigator will provide expertise on aging, disparities and will assist with evaluating the implementation and acceptability of… $58,100
Emory University Emory University (EU) will support study design of the project and is primarily responsible for recruiting and leading collaboration with Community Advisors and… $59,443
Trustees Of Boston College The Boston College Investigator will co-lead the qualitative component of the study and responsibilities will include developing data collection instruments and… $82,584
University Of Maryland, Baltimore The project GOC ADVANCE (Goals of Care-Addressing Disparities and Variation for Alzheimer's disease Nursing home Care at End of Life) will aim to address… $548,269
Hebrew Rehabilitation Center The Hebrew Rehabilitation Center (HRC) will contribute to all aspects of designing the trial, assessing and advising on its conduct, planning the analytic… $45,755

Quick answers

Who received award R01AG091541?

R01AG091541 was awarded to University Of North Carolina At Chapel Hill by National Institute on Aging (National Institutes of Health) on September 10, 2025.

How much is award R01AG091541 worth?

$1,628,644 has been obligated on R01AG091541.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award